Inequities Identified in Ophthalmologic Care, Research
MONDAY, Dec. 12, 2022 (HealthDay News) — Various inequities have been identified in ophthalmologic care, including negative ophthalmic outcomes for Black and Hispanic patients, according to a review published online Dec. 8 in JAMA Ophthalmology.Chris…
Learn MoreWorse Perinatal Outcomes Seen for Babies Born to Minority Moms
MONDAY, Dec. 12, 2022 (HealthDay News) — In high- and upper-middle-income countries, babies born to women from underserved and underrepresented racial and ethnic groups have an increased risk for adverse perinatal outcomes, according to a study publi…
Learn MoreExtreme Temperatures Up Risk for Cardiovascular Mortality
MONDAY, Dec. 12, 2022 (HealthDay News) — Extreme hot and cold temperatures are associated with an increased risk for mortality from common cardiovascular conditions, according to a study published online Dec. 12 in Circulation.Barrak Alahmad, M.D., M…
Learn MoreSports Team Participation Linked to Increased Odds of Vaping
MONDAY, Dec. 12, 2022 (HealthDay News) — Youth sports team participation is associated with increased odds of electronic vapor product (EVP) use, according to a study published online Dec. 12 in Pediatrics.Eli Rapoport, from the New York University G…
Learn MoreAddition of Immunomodulators Cuts Vascular Inflammation in RA
MONDAY, Dec. 12, 2022 (HealthDay News) — For patients with rheumatoid arthritis (RA), the addition of a tumor necrosis factor (TNF) inhibitor (TNFi) or addition of sulfasalazine and hydroxychloroquine (triple therapy) to methotrexate results in clini…
Learn MoreModel Using Nine Urine Metabolites Can Predict Preeclampsia
MONDAY, Dec. 12, 2022 (HealthDay News) — A model including nine urine metabolites can predict preeclampsia early in pregnancy, according to a study published in the Dec. 9 issue of Patterns.Ivana Marić, Ph.D., from the Stanford University School of M…
Learn MoreSABCS: Updated Analysis Confirms Endocrine Therapy Effective With/Without Chemo
MONDAY, Dec. 12, 2022 (HealthDay News) — For patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS) of 11 to 25, adjuvant en…
Learn MoreAntibody Treatment Makes Inroads Against Multiple Myeloma
MONDAY, Dec. 12, 2022 (HealthDay News) — An experimental immunotherapy appears highly effective in attacking bone marrow cancer, with nearly three in four patients responding to the treatment, new clinical trial results show.The drug, talquetamab, wo…
Learn More